School of Medicine
Showing 51-60 of 60 Results
-
Igor D. Bandeira
Postdoctoral Scholar, Psychiatry
BioIgor D. Bandeira, M.D., Ph.D., is a physician-scientist from Salvador in Brazil, working as a Postdoctoral Research Fellow in the Department of Psychiatry and Behavioral Sciences at Stanford University. He completed his Doctor of Medicine (M.D.) at the Federal University of Bahia (Brazil), where he received the prestigious Professor Alfredo Thomé de Britto Award for outstanding graduate scientific research. Part of his medical training took place at the University of Sydney (Australia) through a Science Without Borders Scholarship. In parallel with his formal graduate training, he worked as a researcher at the university’s Brain and Mind Centre during this period. As an attending physician, Dr. Bandeira acquired further clinical experience at the Brazilian Ministry of Health. Furthermore, during the pandemic, Dr. Bandeira worked on the Brazilian frontline in the fight against Covid-19. With respect to research, he has several years’ experience applying noninvasive brain stimulation techniques in the fields of neurology and psychiatry. During his Ph.D. at the Federal University of Bahia, Dr. Bandeira has also acquired expertise in developing clinical trials to test the efficacy of rapid-acting antidepressants. His work involved using ketamine and its enantiomers (e.g., esketamine and arketamine) for treatment-resistant depression (TRD) and bipolar depression. Since he arrived at Stanford, he has built on his previous training in clinical trials by leading (A) the Wellcome LEAP multisite accelerated intermittent theta burst stimulation (Stanford Neuromodulation Therapy) trial for anhedonic depression and co-leading (B) a trial testing the efficacy and safety of buprenorphine in sustaining the anti-suicide properties of ketamine.
-
Tianwei Du
Postdoctoral Scholar, Psychiatry
BioDr. Du's clinical interests focus on providing evidence-based treatment to individuals with emotion dysregulation, interpersonal difficulties, and/or complex trauma. She is also passionate about addressing diversity factors in clinical work. Dr. Du provides services in the Dialectical Behavior Therapy (DBT) Adult Program, the Anxiety and Depression Adult Psychological Treatment (ADAPT) Clinic, and the Stanford Mental Health for Asians Research and Treatment (SMHART) Clinic. Dr. Du is a bilingual clinician speaking English and Mandarin.
Dr. Du's research focuses on exploring the roles of interpersonal processes and personality in psychopathology, and she has published widely on this topic. Dr. Du also participated in a variety of clinical trials to help develop and improve evidence-based interventions for individuals with complex clinical presentations and populations with limited access to mental health care. -
Ramzi Emanuel Dudum
Clinical Scholar, Medicine - Cardiovascular Medicine
Postdoctoral Scholar, General Internal Medicine
Masters Student in Health Policy, admitted Autumn 2022BioDr. Dudum is a cardiologist and population health expert working to develop novel risk prediction methods and implementation strategies to create practices and systems that allow for reductions in cardiovascular disease. He completed a Masters in Public Health at Johns Hopkins concentrating in epidemiology and biostatistics and a Doctorate of Medicine at George Washington University.
He completed internal medicine residency training as part of the Osler Medical Service, where he worked under the mentorship of Drs. Roger Blumenthal and Michael Blaha to study improving cardiovascular risk prediction and coronary artery calcium. Given his focus on population health and implementation science, he also helped launch and refine risk adjustment tools and implemented guideline-directed medical care pathways. During his time there, he was recognized for his clinical acumen and dedication to patient care.
He came to Stanford for his cardiovascular medicine fellowship and continued research in coronary artery calcium under the mentorship of Drs. David Maron and Fatima Rodriguez while also conducting cardiovascular health implementation science work under the mentorship of Dr. Steve Asch. He serves as the co-investigator of a prospective randomized trial testing the effects of notification of incidental coronary artery calcium on statin initiation rates among those with and without cardiovascular disease (NCT 05588895). He has worked with hospital leaders to implement digital health and artificial intelligence tools, creating the infrastructure for the prospective use of AI-algorithms on radiology studies. As a preventive cardiologist and population health expert, he leads efforts in the preventive cardiology section related to improving cardiovascular health.
